The L10P polymorphism and serum levels of transforming growth factorβ1 in human breast cancer

International Journal of Molecular Sciences

Volumn 14, Issue 8, 2013, Pages 15376-15385

  Taubenschuß, Eva ^a   Marton, Erika ^a   Mogg, Maurice ^a   Frech, Barbara ^a   Ehart, Lisa ^a   Muin, Dana ^a   Schreiber, Martin ^a,b  

^a UNIV KLIN FÜR FRAUENHEILKUNDE   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Breast cancer; L10P SNP; rs1800470; Serum levels; TGF 1

Indexed keywords

LEUCINE; PROLINE; TRANSFORMING GROWTH FACTOR BETA1;

ALLELE; ARTICLE; BREAST CANCER; CANCER GROWTH; CANCER RISK; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETIC ASSOCIATION; GENOTYPE; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; SINGLE NUCLEOTIDE POLYMORPHISM;

BREAST NEOPLASMS; FEMALE; GENOTYPE; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN ISOFORMS; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84880725541     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms140815376     Document Type: Article

References (28)

1. Massague, J. TGFbeta in Cancer. Cell 2008, 134, 215-230.
2. Pardali, K.; Moustakas, A. Actions of TGF-beta as tumor suppressor and pro-metastatic factor in human cancer. Biochim. Biophys. Acta 2007, 1775, 21-62.
3. Siegel, P.M.; Massague, J. Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer. Nat. Rev. Cancer 2003, 3, 807-821.
4. Padua, D.; Massague, J. Roles of TGF-beta in metastasis. Cell Res. 2009, 19, 89-102.
5. Imamura, T.; Hikita, A.; Inoue, Y. The roles of TGF-beta signaling in carcinogenesis and breast cancer metastasis. Breast Cancer 2012, 19, 118-124.
6. Cox, A.; Dunning, A.M.; Garcia-Closas, M.; Balasubramanian, S.; Reed, M.W.; Pooley, K.A.; Scollen, S.; Baynes, C.; Ponder, B.A.; Chanock, S et al. A common coding variant in CASP8 is associated with breast cancer risk. Nat. Genet. 2007, 39, 352-358.
7. Dunning, A.M.; Ellis, P.D.; McBride, S.; Kirschenlohr, H.L.; Healey, C.S.; Kemp, P.R.; Luben, R.N.; Chang-Claude, J.; Mannermaa, A.; Kataja, V et al. A transforming growth factor beta1 signal peptide variant increases secretion in vitro and is associated with increased incidence of invasive breast cancer. Cancer Res. 2003, 63, 2610-2615.
8. Lee, K.M.; Park, S.K.; Hamajima, N.; Tajima, K.; Yoo, K.Y.; Shin, A.; Noh, D.Y.; Ahn, S.H.; Hirvonen, A.; Kang, D. Genetic polymorphisms of TGF-beta1 & TNF-beta and breast cancer risk. Breast Cancer Res. Treat. 2005, 90, 149-155.
9. Shu, X.O.; Gao, Y.T.; Cai, Q.; Pierce, L.; Cai, H.; Ruan, Z.X.; Yang, G.; Jin, F.; Zheng, W. Genetic polymorphisms in the TGF-beta 1 gene and breast cancer survival: A report from the Shanghai Breast Cancer Study. Cancer Res. 2004, 64, 836-839.
10. Ziv, E.; Cauley, J.; Morin, P.A.; Saiz, R.; Browner, W.S. Association between the T29→C polymorphism in the transforming growth factor β1 gene and breast cancer among elderly white women: The study of osteoporotic fractures. JAMA 2001, 285, 2859-2863.
11. Cox, D.G.; Penney, K.; Guo, Q.; Hankinson, S.E.; Hunter, D.J. TGFB1 and TGFBR1 polymorphisms and breast cancer risk in the Nurses' Health Study. BMC Cancer 2007, 7, 175.
12. Feigelson, H.S.; Patel, A.V.; Diver, W.R.; Stevens, V.L.; Thun, M.J.; Calle, E.E. Transforming growth factor beta receptor type I and transforming growth factor beta1 polymorphisms are not associated with postmenopausal breast cancer. Cancer Epidemiol. Biomark. Prev. 2006, 15, 1236-1237.
13. Jin, Q.; Hemminki, K.; Grzybowska, E.; Klaes, R.; Soderberg, M.; Zientek, H.; Rogozinska-Szczepka, J.; Utracka-Hutka, B.; Pamula, J.; Pekala, W et al. Polymorphisms and haplotype structures in genes for transforming growth factor beta1 and its receptors in familial and unselected breast cancers. Int. J. Cancer 2004, 112, 94-99.
14. Kaklamani, V.G.; Baddi, L.; Liu, J.; Rosman, D.; Phukan, S.; Bradley, C.; Hegarty, C.; McDaniel, B.; Rademaker, A.; Oddoux, C et al. Combined genetic assessment of transforming growth factor-beta signaling pathway variants may predict breast cancer risk. Cancer Res. 2005, 65, 3454-3461.
15. Krippl, P.; Langsenlehner, U.; Renner, W.; Yazdani-Biuki, B.; Wolf, G.; Wascher, T.C.; Paulweber, B.; Bahadori, B.; Samonigg, H. The L10P polymorphism of the transforming growth factor-beta 1 gene is not associated with breast cancer risk. Cancer Lett. 2003, 201, 181-184.
16. Le Marchand, L.; Haiman, C.A.; van den Berg, D.; Wilkens, L.R.; Kolonel, L.N.; Henderson, B.E. T29C polymorphism in the transforming growth factor beta1 gene and postmenopausal breast cancer risk: The Multiethnic Cohort Study. Cancer Epidemiol. Biomark. Prev. 2004, 13, 412-415.
17. Mu, L.; Katsaros, D.; Lu, L.; Preti, M.; Durando, A.; Arisio, R.; Yu, H. TGF-β1 genotype and phenotype in breast cancer and their associations with IGFs and patient survival. Br. J. Cancer 2008, 99, 1357-1363.
18. Rebbeck, T.R.; Antoniou, A.C.; Llopis, T.C.; Nevanlinna, H.; Aittomaki, K.; Simard, J.; Spurdle, A.B.; Couch, F.J.; Pereira, L.H.; Greene, M.H.; et al. No association of TGFB1 L10P genotypes and breast cancer risk in BRCA1 and BRCA2 mutation carriers: A multi-center cohort study. Breast Cancer Res. Treat. 2009, 115, 185-192.
19. Shin, A.; Shu, X.O.; Cai, Q.; Gao, Y.T.; Zheng, W. Genetic polymorphisms of the transforming growth factor-beta1 gene and breast cancer risk: A possible dual role at different cancer stages. Cancer Epidemiol. Biomark. Prev. 2005, 14, 1567-1570.
20. Sigurdson, A.J.; Hauptmann, M.; Chatterjee, N.; Alexander, B.H.; Doody, M.M.; Rutter, J.L.; Struewing, J.P. Kin-cohort estimates for familial breast cancer risk in relation to variants in DNA base excision repair, BRCA1 interacting and growth factor genes. BMC Cancer 2004, 4, 9.
21. Hishida, A.; Iwata, H.; Hamajima, N.; Matsuo, K.; Mizutani, M.; Iwase, T.; Miura, S.; Emi, N.; Hirose, K.; Tajima, K. Transforming growth factor B1 T29C polymorphism and breast cancer risk in Japanese women. Breast Cancer 2003, 10, 63-69.
22. Zheng, W. Genetic polymorphisms in the transforming growth factor-beta signaling pathways and breast cancer risk and survival. Methods Mol. Biol. 2009, 472, 265-277.
23. Guo, J.; Meng, H.; Pei, J.; Zhu, M. Association between the TNF-alpha-238G > A and TGF-beta1 L10P polymorphisms and breast cancer risk: A meta-analysis. Breast Care 2011, 6, 126-129.
24. Huang, Y.; Li, B.; Qian, J.; Xie, J.; Yu, L. TGF-beta1 29T/C polymorphism and breast cancer risk: A meta-analysis involving 25,996 subjects. Breast Cancer Res. Treat. 2010, 123, 863-868.
25. Yokota, M.; Ichihara, S.; Lin, T.L.; Nakashima, N.; Yamada, Y. Association of a T29→C polymorphism of the transforming growth factor-beta1 gene with genetic susceptibility to myocardial infarction in Japanese. Circulation 2000, 101, 2783-2787.
26. Li, X.; Yue, Z.C.; Zhang, Y.Y.; Bai, J.; Meng, X.N.; Geng, J.S.; Fu, S.B. Elevated serum level and gene polymorphisms of TGF-beta1 in gastric cancer. J. Clin. Lab Anal. 2008, 22, 164-171.
27. Proestling, K.; Hebar, A.; Pruckner, N.; Marton, E.; Vinatzer, U.; Schreiber, M. The pro allele of the p53 codon 72 polymorphism is associated with decreased intratumoral expression of BAX and p21, and increased breast cancer risk. PLoS One 2012, 7, e47325.
28. R Development Core Team. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing: Vienna, Austria, 2009.